Disruption of the HIV‐1 protease dimer with interface peptides: Structural studies using NMR spectroscopy combined with [2‐13C]‐Trp selective labeling
Open Access
- 18 January 2007
- journal article
- research article
- Published by Wiley in Peptide Science
- Vol. 88 (2) , 164-173
Abstract
HIV‐1 protease (HIV‐1 PR), which is encoded by retroviruses, is required for the processing of gag and pol polyprotein precursors, hence it is essential for the production of infectious viral particles. In vitro inhibition of the enzyme results in the production of progeny virions that are immature and noninfectious, suggesting its potential as a therapeutic target for AIDS. Although a number of potent protease inhibitor drugs are now available, the onset of resistance to these agents due to mutations in HIV‐1 PR has created an urgent need for new means of HIV‐1 PR inhibition. Whereas enzymes are usually inactivated by blocking of the active site, the structure of dimeric HIV‐1 PR allows an alternative inhibitory mechanism. Since the active site is formed by two half‐enzymes, which are connected by a four‐stranded antiparallel β‐sheet involving the N‐ and C‐ termini of both monomers, enzyme activity can be abolished by reagents targeting the dimer interface in a region relatively free of mutations would interfere with formation or stability of the functional HIV‐1 PR dimer. This strategy has been explored by several groups who targeted the four‐stranded antiparallel β‐sheet that contributes close to 75% of the dimerization energy. Interface peptides corresponding to native monomer N‐ or C‐termini of several of their mimetics demonstrated, mainly on the basis of kinetic analyses, to act as dimerization inhibitors. However, to the best of our knowledge, neither X‐ray crystallography nor NMR structural studies of the enzyme‐inhibitor complex have been performed to date. In this article we report a structural study of the dimerization inhibition of HIV‐1 PR by NMR using selective Trp side chain labeling. © 2007 Wiley Periodicals, Inc. Biopolymers (Pept Sci) 88: 164–173, 2007.This article was originally published online as an accepted preprint. The ‘Published Online’ date corresponds to the preprint version. You can request a copy of the preprint by emailing the Biopolymers editorial office at biopolymers@wiley.comKeywords
This publication has 30 references indexed in Scilit:
- Solution Structure of the Mature HIV-1 Protease MonomerJournal of Biological Chemistry, 2003
- Use of Selective Trp Side Chain Labeling To Characterize Protein−Protein and Protein−Ligand Interactions by NMR SpectroscopyJournal of the American Chemical Society, 2003
- Revisiting Monomeric HIV-1 ProteaseJournal of Biological Chemistry, 2003
- Control of Viremia and Prevention of Clinical AIDS in Rhesus Monkeys by Cytokine-Augmented DNA VaccinationScience, 2000
- NMR-Based Screening of Proteins Containing 13C-Labeled Methyl GroupsJournal of the American Chemical Society, 2000
- Design, Synthesis, and Evaluation of Conformationally Constrained Tongs, New Inhibitors of HIV-1 Protease DimerizationJournal of Medicinal Chemistry, 1999
- NMR spectroscopy as a tool for structure-based drug designProgress in Nuclear Magnetic Resonance Spectroscopy, 1998
- Targeting the Dimerization Interface of HIV-1 Protease: Inhibition with Cross-Linked Interfacial PeptidesJournal of the American Chemical Society, 1997
- The HIV-1 Protease as Enzyme and Substrate: Mutagenesis of Autolysis Sites and Generation of a Stable Mutant with Retained Kinetic PropertiesBiochemistry, 1994
- Secondary structure and signal assignments of human‐immunodeficiency‐virus‐1 protease complexed to a novel, structure‐based inhibitorEuropean Journal of Biochemistry, 1994